
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/base_style-CPPDhfna.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-BepKMsUl.js"></script>

  <link rel="stylesheet" href="/static/assets/article_style-DUfI1jZp.css" />
<link rel="stylesheet" href="/static/assets/style-BOrsu84o.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-D3wJHomh.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025) - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="E0CA2433930AF7E300243300346B3C70.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="healthcare">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Healthcare">
<meta name="citation_title" content="Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025)">
<meta name="citation_author" content="Hadi A Almansour">
<meta name="citation_author_institution" content="Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.);">
<meta name="citation_author_institution" content="Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia">
<meta name="citation_author" content="Hilal A Thaibah">
<meta name="citation_author_institution" content="Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.);">
<meta name="citation_author_institution" content="Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia">
<meta name="citation_author" content="Moaddey Alfarhan">
<meta name="citation_author_institution" content="Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.);">
<meta name="citation_author_institution" content="Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia">
<meta name="citation_author" content="Saeed A Al-Qahtani">
<meta name="citation_author_institution" content="Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.);">
<meta name="citation_author_institution" content="Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia">
<meta name="citation_author" content="Amani A Khardali">
<meta name="citation_author_institution" content="Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.);">
<meta name="citation_author_institution" content="Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia">
<meta name="citation_author" content="Thamir M Alshammari">
<meta name="citation_author_institution" content="Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.);">
<meta name="citation_author_institution" content="Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia">
<meta name="citation_publication_date" content="2025 Sep 9">
<meta name="citation_volume" content="13">
<meta name="citation_issue" content="18">
<meta name="citation_firstpage" content="2259">
<meta name="citation_doi" content="10.3390/healthcare13182259">
<meta name="citation_pmid" content="41008391">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/pdf/healthcare-13-02259.pdf">
<meta name="description" content="Background: Tirzepatide (Mounjaro or Zepbound), a dual GLP-1/GIP receptor agonist, is approved for type 2 diabetes and weight management. Despite its efficacy, real-world safety data remain limited. This study analyzed post-marketing adverse events ...">
<meta name="og:title" content="Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025)">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Background: Tirzepatide (Mounjaro or Zepbound), a dual GLP-1/GIP receptor agonist, is approved for type 2 diabetes and weight management. Despite its efficacy, real-world safety data remain limited. This study analyzed post-marketing adverse events ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12469573">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/healthcare13182259"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/healthcare-13-02259.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12469573%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12469573/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12469573/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-healthcare.png" alt="Healthcare logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Healthcare" title="Link to Healthcare" shape="default" href="http://www.mdpi.com/journal/healthcare" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Healthcare (Basel)</button></div>. 2025 Sep 9;13(18):2259. doi: <a href="https://doi.org/10.3390/healthcare13182259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/healthcare13182259</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Healthcare%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Healthcare%20(Basel)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Healthcare%20(Basel)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Healthcare%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025)</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almansour%20HA%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Hadi A Almansour</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Hadi A Almansour</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.); </div>
<div class="p">
<sup>2</sup>Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia</div>
<div>Conceptualization, Methodology, Validation, Formal analysis, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almansour%20HA%22%5BAuthor%5D" class="usa-link"><span class="name western">Hadi A Almansour</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thaibah%20HA%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Hilal A Thaibah</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Hilal A Thaibah</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.); </div>
<div class="p">
<sup>2</sup>Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia</div>
<div>Conceptualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thaibah%20HA%22%5BAuthor%5D" class="usa-link"><span class="name western">Hilal A Thaibah</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alfarhan%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Moaddey Alfarhan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Moaddey Alfarhan</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.); </div>
<div class="p">
<sup>2</sup>Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia</div>
<div>Conceptualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alfarhan%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Moaddey Alfarhan</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Al-Qahtani%20SA%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Saeed A Al-Qahtani</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Saeed A Al-Qahtani</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.); </div>
<div class="p">
<sup>2</sup>Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia</div>
<div>Conceptualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Al-Qahtani%20SA%22%5BAuthor%5D" class="usa-link"><span class="name western">Saeed A Al-Qahtani</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khardali%20AA%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Amani A Khardali</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Amani A Khardali</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.); </div>
<div class="p">
<sup>2</sup>Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia</div>
<div>Conceptualization, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khardali%20AA%22%5BAuthor%5D" class="usa-link"><span class="name western">Amani A Khardali</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alshammari%20TM%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Thamir M Alshammari</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Thamir M Alshammari</span></h3>
<div class="p">
<sup>1</sup>Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.); </div>
<div class="p">
<sup>2</sup>Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia</div>
<div>Conceptualization, Methodology, Formal analysis, Data curation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alshammari%20TM%22%5BAuthor%5D" class="usa-link"><span class="name western">Thamir M Alshammari</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Janko Samardžić</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-healthcare-13-02259">
<sup>1</sup>Department of Clinical Practice, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia; halmansour@jazanu.edu.sa (H.A.A.); </div>
<div id="af2-healthcare-13-02259">
<sup>2</sup>Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia</div>
<div class="author-notes p"><div class="fn" id="c1-healthcare-13-02259">
<sup>*</sup><p class="display-inline">Correspondence: <span>talshammari@jazanu.edu.sa</span></p>
</div></div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Hadi A Almansour</span></strong>: <span class="role">Conceptualization, Methodology, Validation, Formal analysis, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Hilal A Thaibah</span></strong>: <span class="role">Conceptualization, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Moaddey Alfarhan</span></strong>: <span class="role">Conceptualization, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Saeed A Al-Qahtani</span></strong>: <span class="role">Conceptualization, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Amani A Khardali</span></strong>: <span class="role">Conceptualization, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Thamir M Alshammari</span></strong>: <span class="role">Conceptualization, Methodology, Formal analysis, Data curation, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Janko Samardžić</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jul 21; Revised 2025 Aug 24; Accepted 2025 Sep 6; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12469573  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/41008391/" class="usa-link">41008391</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p><strong>Background</strong>: Tirzepatide (Mounjaro or Zepbound), a dual GLP-1/GIP receptor agonist, is approved for type 2 diabetes and weight management. Despite its efficacy, real-world safety data remain limited. This study analyzed post-marketing adverse events (AEs) associated with tirzepatide using the FDA Adverse Event Reporting System (FAERS) to identify emerging safety concerns. <strong>Methods</strong>: FAERS reports from 2022 to Q1 2025 were analyzed. Disproportionality analyses (proportional reporting ratio [PRR], reporting odds ratio [ROR], empirical Bayes geometric mean [EBGM], and information component [IC]) were performed to detect safety signals. Reports were stratified by year, demographics, and AE type, focusing on cases in which tirzepatide was the primary suspect. <strong>Results</strong>: Among 65,974 reports, the majority originated from the U.S. (96%), with middle-aged females (40–59 years; 67%) most frequently affected. Incorrect dose administration was the top AE, increasing 8-fold from 1248 (2022) to 9800 (2024), with strong risk signals (ROR 22.15, 95% CI (20.75–23.65), and ROR 23.43, 95% CI (22.82–24.05), respectively, and PRR 16.80, 95% CI (15.74–17.93), and PRR 17.62, 95% CI (17.16–18.09), respectively). Other common AEs included injection-site reactions (e.g., pain [5273 cases in 2024]), gastrointestinal issues (nausea [3602 in 2024]), and off-label use. Class-related AEs (e.g., decreased appetite and blood glucose fluctuations) were also reported. <strong>Conclusions</strong>: Tirzepatide is associated with significant dosing errors, injection-site reactions, and gastrointestinal AEs in real-world use. The rising trend in reports underscores the need for enhanced provider and patient education, clearer dosing guidelines, and proactive monitoring. Further research is warranted to explore causative factors and optimize risk mitigation strategies.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> adverse drug events, FAERS, GLP-1 agonists, medication errors, Mounjaro, pharmacovigilance, tirzepatide, Zepbound</p></section></section><section id="sec1-healthcare-13-02259"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Tirzepatide (Mounjaro or Zepbound) is a medication used for managing type 2 diabetes, after it was approved by the FDA in May 2022, and, more recently (November 2023), for weight management [<a href="#B1-healthcare-13-02259" class="usa-link" aria-describedby="B1-healthcare-13-02259">1</a>,<a href="#B2-healthcare-13-02259" class="usa-link" aria-describedby="B2-healthcare-13-02259">2</a>]. It is a glucagon-like peptide-1 (GLP-1) receptor agonist used to regulate blood glucose levels [<a href="#B2-healthcare-13-02259" class="usa-link" aria-describedby="B2-healthcare-13-02259">2</a>]. Clinical trials have demonstrated that tirzepatide can lead to substantial weight loss in individuals with and without diabetes [<a href="#B3-healthcare-13-02259" class="usa-link" aria-describedby="B3-healthcare-13-02259">3</a>]. However, long-term safety data on it for this indication are still being collected [<a href="#B3-healthcare-13-02259" class="usa-link" aria-describedby="B3-healthcare-13-02259">3</a>,<a href="#B4-healthcare-13-02259" class="usa-link" aria-describedby="B4-healthcare-13-02259">4</a>]. There have been many social media advertisements and influencers promoting the use of tirzepatide for weight loss [<a href="#B5-healthcare-13-02259" class="usa-link" aria-describedby="B5-healthcare-13-02259">5</a>]. It has attracted attention both for its effectiveness and for possible side effects [<a href="#B5-healthcare-13-02259" class="usa-link" aria-describedby="B5-healthcare-13-02259">5</a>]. Thus, the safety of tirzepatide needs to be understood by healthcare providers and patients.</p>
<p>Medication errors remain a major concern in healthcare, affecting patient safety, treatment efficacy, and healthcare cost [<a href="#B6-healthcare-13-02259" class="usa-link" aria-describedby="B6-healthcare-13-02259">6</a>,<a href="#B7-healthcare-13-02259" class="usa-link" aria-describedby="B7-healthcare-13-02259">7</a>]. Since medication errors can cause avoidable adverse drug events (ADEs), it is important to know the factors that cause such medication errors to enhance patient safety [<a href="#B7-healthcare-13-02259" class="usa-link" aria-describedby="B7-healthcare-13-02259">7</a>]. Medication errors are possible at all phases of the medication therapy process, including prescribing, transcribing, dispensing, administering, and monitoring, and at all levels of these processes [<a href="#B8-healthcare-13-02259" class="usa-link" aria-describedby="B8-healthcare-13-02259">8</a>]. Such errors may result in ADEs, which are frequently avoidable. The American Society of Health-System Pharmacists (ASHP) has worked to prevent these mistakes, with a principal focus on system-level changes in, as well to improve, hospitals [<a href="#B9-healthcare-13-02259" class="usa-link" aria-describedby="B9-healthcare-13-02259">9</a>]. In a systematic review, Assiri et al. (2018) defined the epidemiology of medication errors and types of common errors and risk factors at the level of the community-care environment [<a href="#B10-healthcare-13-02259" class="usa-link" aria-describedby="B10-healthcare-13-02259">10</a>]. It was indicated that there is a need for better reporting and monitoring of errors to better grasp the size of the problem.</p>
<p>There are reports of medication errors and safety concerns in the Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) database. The FAERS is a system that aids the FDA’s post-marketing safety surveillance program for all marketed drugs and therapeutic biologic products [<a href="#B11-healthcare-13-02259" class="usa-link" aria-describedby="B11-healthcare-13-02259">11</a>]. It includes adverse event reports that are provided by manufacturers as required by regulation, in addition to reports provided directly by healthcare providers and consumers/patients. Using the FAERS data, investigators can identify and describe adverse events (AEs) unique to tirzepatide to build its safety profile in relation to other drugs sharing common side effect profiles.</p>
<p>Several studies have underlined the importance of discovering drug combinations that mitigate ADEs [<a href="#B12-healthcare-13-02259" class="usa-link" aria-describedby="B12-healthcare-13-02259">12</a>,<a href="#B13-healthcare-13-02259" class="usa-link" aria-describedby="B13-healthcare-13-02259">13</a>]. Since tirzepatide can potentially be used in combination with several adjunctive diabetes therapies, knowledge of possible drug interactions is relevant [<a href="#B12-healthcare-13-02259" class="usa-link" aria-describedby="B12-healthcare-13-02259">12</a>]. This could suggest that analysis of FAERS data on tirzepatide may provide insights into interactions that either worsen or mitigate ADEs [<a href="#B14-healthcare-13-02259" class="usa-link" aria-describedby="B14-healthcare-13-02259">14</a>] and, therefore, have implications for developing clinical guidelines for safer prescribing practices. Although there are barriers that may impact medication error reporting, the resolution of these barriers is critical for the appropriate characterization of the safety record of tirzepatide in the FAERS database, in turn, paving the way for more stringent policies to protect patients [<a href="#B15-healthcare-13-02259" class="usa-link" aria-describedby="B15-healthcare-13-02259">15</a>,<a href="#B16-healthcare-13-02259" class="usa-link" aria-describedby="B16-healthcare-13-02259">16</a>].</p>
<p>Pharmacological safety is an absolute concern in clinical settings. Various research studies describe the growing adoption of herbal medicines, and the issue of how adverse reactions are monitored demonstrates the need for strong methodologies to evaluate them [<a href="#B17-healthcare-13-02259" class="usa-link" aria-describedby="B17-healthcare-13-02259">17</a>]. This is consistent in many studies, which report a substantial prevalence of underreporting of AEs for novel drugs, such as tirzepatide [<a href="#B18-healthcare-13-02259" class="usa-link" aria-describedby="B18-healthcare-13-02259">18</a>]. Development of integrated surveillance systems is urgent, and especially relevant for drugs with new mechanisms of action like tirzepatide. Thus, the aim of this study is to provide an overview of the safety profile of tirzepatide, including medication errors, ADEs, and other safety issues using the FAERS database.</p></section><section id="sec2-healthcare-13-02259"><h2 class="pmc_sec_title">2. Methods</h2>
<p>The study utilized data from the FAERS, covering reports from 2022 to 2025. Reports are submitted by various sources globally, including healthcare professionals, pharmaceutical manufacturers, lawyers, and patients. This database is freely accessible on the FDA’s website and is updated every three months [<a href="#B19-healthcare-13-02259" class="usa-link" aria-describedby="B19-healthcare-13-02259">19</a>]. The FAERS database is structured into the following seven distinct file types: Demographic and Administrative Information (DEMO), Adverse Events (REAC), Patient Outcomes (OUTC), Report Sources (RPSR), Drug Information (DRUG), Indications for Use (INDI), and Start and End Dates for Reported Drugs (THER). These sub-databases are classified based on the reporter type, including consumers, physicians, pharmacists, other healthcare professionals, or lawyers. Reported patient outcomes include death, hospitalization, disability, or other unspecified outcomes, all of which require intervention to be prevented. The country of the reporters indicates the basis of the latest report version, which can be inside or outside the U.S. Patient age is recorded numerically at the time of the event [<a href="#B19-healthcare-13-02259" class="usa-link" aria-describedby="B19-healthcare-13-02259">19</a>,<a href="#B20-healthcare-13-02259" class="usa-link" aria-describedby="B20-healthcare-13-02259">20</a>]. To link all datasets for the study, a unique identifier called “primaryid” was used. It is important to note that the U.S. FDA requires pharmaceutical manufacturers to report adverse drug reactions (ADRs) for their products. Consumers/patients and healthcare professionals are also recommended to submit ADR reports, despite their location [<a href="#B21-healthcare-13-02259" class="usa-link" aria-describedby="B21-healthcare-13-02259">21</a>,<a href="#B22-healthcare-13-02259" class="usa-link" aria-describedby="B22-healthcare-13-02259">22</a>].</p>
<p>The data retrieved from the FAERS for this study, from 2022 to the first quarter of 2025, are meant to demonstrate the safety concerns of tirzepatide use. The FAERS database uses the Medical Dictionary for Regulatory Activities’ (MedDRA) coding system, which employs preferred terms (PTs) to categorize AEs. The study was conducted in two phases to (1) find all AEs related to the drug of interest and (2) perform a disproportionality analysis on the most reported AEs. Reports were retrieved using the “drugname” and “prod_ai” variables. To minimize bias from other medications, only reports where tirzepatide was listed as the primary suspected (PS) cause of the adverse event were included. In addition, duplicate reports were identified and removed using the “primaryid”, event date (event_dt), and “pt” variables.</p>
<p>A non-case disproportionate/pharmacovigilance case analysis was performed to assess the risk of the most reported AEs linked to tirzepatide. In this analysis, “cases” were defined as potential AE reports associated with tirzepatide, while “non-cases” included all other AE reports for tirzepatide.</p>
<p>Both Bayesian and traditional statistical methods were used to evaluate possible safety concerns. A 2 × 2 contingency table was utilized to analyze the following four key metrics: “a” (cases for the studied medication), “b” (non-cases for the studied medication), “c” (cases for other medications), and “d” (non-cases for other medications) (<a href="#healthcare-13-02259-t001" class="usa-link">Table 1</a>). A dual-method approach was used to improve the reliability of the analysis and decrease the chance of inaccurate results. The disproportionality metrics calculated included the proportional reporting ratio (PRR), reporting odds ratio (ROR), information component (IC), and empirical Bayes geometric mean (EBGM). A safety signal was indicated if the results met specific criteria across the following metrics: an ROR above one, a PRR of two or higher, an EBGM exceeding two, or an IC value greater than zero [<a href="#B22-healthcare-13-02259" class="usa-link" aria-describedby="B22-healthcare-13-02259">22</a>,<a href="#B23-healthcare-13-02259" class="usa-link" aria-describedby="B23-healthcare-13-02259">23</a>].</p>
<section class="tw xbox font-sm" id="healthcare-13-02259-t001"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Contingency table for disproportionality analyses.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Adverse Drug Reaction of Interest</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Other Adverse Drug Reactions</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Drug of interest</td>
<td align="center" valign="middle" rowspan="1" colspan="1">a</td>
<td align="center" valign="middle" rowspan="1" colspan="1">b</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All other drugs in the database</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">d</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/healthcare-13-02259-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>To ensure reliability and minimize false associations, significant signals were required to meet the criteria for all four metrics. All statistical analyses were conducted using R software (version 4.2.2) and R Studio (version 2024.04.2+764).</p></section><section id="sec3-healthcare-13-02259"><h2 class="pmc_sec_title">3. Results</h2>
<p>A total of 65,974 tirzepatide reports were retrieved from the U.S. FAERS database (<a href="#healthcare-13-02259-t002" class="usa-link">Table 2</a>). The majority of reports were submitted by females (44,120; 66.9%), followed by males (13,410; 20.3%), while 8444 (12.8%) were by an unspecified sex. Regarding age, the highest number of reports came from individuals aged 40 to 59 years (21,809; 33.1%), followed by those aged 60 to 89 years (12,943; 19.6%) and those aged 18 to 39 years (7519; 11.4%). Reports involving children under 18 were infrequent (16; 0.02%). Notably, 23,666 reports (35.9%) did not specify age.</p>
<section class="tw xbox font-sm" id="healthcare-13-02259-t002"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Demographics of tirzepatide adverse event reports.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristic</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Category</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Reports (%)</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<strong>Sex</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Female (F)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">44,120 (66.9)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Male (M)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13,410 (20.3)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown (UNK)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8444 (12.8)</td>
</tr>
<tr>
<td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<strong>Age</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">(&lt;18 years)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">16 (0.02)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(18–39 years)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7519 (11.4)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(40–59 years)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">21,809 (33.1)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(60–89 years)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12,943 (19.6)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">(≥90 years)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">21 (0.04)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown (UNK)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23,666 (35.9)</td>
</tr>
<tr>
<td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<strong>Reporter</strong>
<br>
<strong>Type</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Healthcare Professional (HP)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2062 (3.1)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Medical Doctor (MD)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1110 (1.7)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Pharmacist (PH)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">691 (1.0)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Consumer (CN)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">61,838 (93.7)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Lawyer (LW)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">222 (0.3)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Other/Unknown</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51 (0.1)</td>
</tr>
<tr>
<td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<strong>Outcome</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Death (DE)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">221 (0.3)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Hospitalization (HO)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2418 (3.7)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Disability (DS)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">181 (0.3)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Other (OT)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3983 (6.0)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown (UNK)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59,171 (89.7)</td>
</tr>
<tr>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<strong>Reporting Country</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">United States (US)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">63,664 (96.5)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">United Kingdom (GB)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1187 (1.8)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Japan (JP)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">522 (0.8)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Others (20+ countries)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">601 (0.9)</td>
</tr>
<tr>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<strong>Reporting Year</strong>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2022</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4931 (7.5)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">2023</td>
<td align="center" valign="middle" rowspan="1" colspan="1">20,600 (31.2)</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">2024</td>
<td align="center" valign="middle" rowspan="1" colspan="1">37,854 (57.4)</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Q1 2025 </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2589 (3.9)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/healthcare-13-02259-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Regarding reporter types, consumers (61,838; 93.7%) were the predominant source of reports. Among healthcare professionals, medical doctors submitted 1110 (1.7%) reports, pharmacists submitted 691 (1.0%), and other healthcare professionals contributed 2062 (3.1%). A smaller portion of reports originated from lawyers (222; 0.3%), and 51 (0.1%) were from other or unknown sources.</p>
<p>The most frequently reported outcomes were categorized as unknown (59,171; 89.7%). Among the known outcomes, hospitalization (2418; 3.7%) was the most common, followed by other outcomes (3983; 6.0%), death (221; 0.3%), and disability (181; 0.3%).</p>
<p>Geographically, the majority of reports came from the United States (63,664; 96.5%), followed by the United Kingdom (1187; 1.8%), Japan (522; 0.8%), and other countries (601; 0.9%).</p>
<p>Report submissions increased significantly over time, with 4931 (7.5%) in 2022; 20,600 (31.2%) in 2023; 37,854 (57.4%) in 2024; and 2589 (3.9%) in the first quarter of 2025.</p>
<p><a href="#healthcare-13-02259-t003" class="usa-link">Table 3</a> shows a significant increase in the AE reports linked to tirzepatide from 2022 to the first quarter of 2025, particularly related to incorrect dose administration. The AE reports surged from 4931 (2022) to 37,854 (2024). Furthermore, the risk signals remained high, i.e., reporting odds ratio (ROR), as it consistently increased (22.15–27.31), peaking in 2023. Also, proportional reporting ratios (PRRs) were similarly high (16.80–19.87), indicating a strong association. However, EBGM and IC slightly declined in 2024 but still signaled significant risk.</p>
<section class="tw xbox font-sm" id="healthcare-13-02259-t003"><h3 class="obj_head">Table 3.</h3>
<div class="caption p"><p>Risk of incorrect dose administered and the use of tirzepatide during 2022 to Q1 2025.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Incorrect Dose Administration ADEs</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reported ADEs for the Drug of Interest</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ROR<br>(95% CI)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PRR<br>(95% CI)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EBGM</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>2022</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1248</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4931</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.15<br>(20.75–23.65)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.80<br>(15.74–17.93)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.01</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.00</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>2023</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5824</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20,600</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.31<br>(26.43–28.23)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.87<br>(19.23–20.54)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.10</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.00</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>2024</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9800</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37,854</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.43<br>(22.82–24.05)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.62<br>(17.16–18.09)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.68</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.66</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<strong>Q1 2025</strong>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2589</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11,206</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.61<br>(16.75–18.52)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.78<br>(13.10–14.49)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.13</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.34</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/healthcare-13-02259-t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section id="sec3dot1-healthcare-13-02259"><h3 class="pmc_sec_title">3.1. Most Reported Adverse Events (Consistently Top 5)</h3>
<p>Reviewing individual adverse events from 2022 to Q1 2025 showed that “Incorrect Dose Administered” was the most common, with 19,461 reports (<a href="#healthcare-13-02259-t004" class="usa-link">Table 4</a>). This event type saw a significant increase over the years, rising from 1248 in 2022 to 9800 in 2024, as well as adding 2589 more reports in Q1 2025. “Injection-site Pain” was the second most reported event, with 9849 reports. This adverse event saw a steady increase each year, reaching its peak at 5273 reports in 2024. Nausea ranked third, with 7678 reports from 2022 to Q1 2025. It remained a consistent gastrointestinal complaint, increasing from 655 in 2022 to 3602 in 2024. The fourth most reported event was “Off-label Use”, with 6993 total reports, which peaked in 2023 (3162 reports). The fifth was “Extra Dose Administered”, which accounted for 5044 reports. This event also showed a sharp increase from 283 in 2022 to 2984 reports in 2024.</p>
<section class="tw xbox font-sm" id="healthcare-13-02259-t004"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>The most frequent adverse event signals associated with tirzepatide between 2022 and Q1 2025.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Adverse Event</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2022</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2023</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2024</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Q1 2025</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Incorrect dose administered</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1248</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5824</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9800</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2589</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19,461</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Injection-site pain</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">592</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2946</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5273</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1038</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9849</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nausea</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">655</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2390</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3602</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1031</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7678</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Off-label use</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">748</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3162</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2704</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">379</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6993</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extra dose administered</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">283</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1078</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2984</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">699</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5044</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Injection-site hemorrhage</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">289</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1344</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2056</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">370</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4059</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diarrhea</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">286</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1056</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1787</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">619</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3748</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Injection-site erythema</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">153</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">987</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1747</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">376</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3263</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vomiting</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">268</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">885</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1573</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">515</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3241</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Accidental underdose</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1981</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">485</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2466</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Constipation</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">703</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1171</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">370</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2244</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Product dose omission issue</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">593</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1122</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">468</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2183</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Injection-site bruising</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">588</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1169</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">269</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2163</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blood glucose increased</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">547</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1019</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1566</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fatigue</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">111</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">809</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">222</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1142</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inappropriate schedule of product administration</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">184</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">737</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">921</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased appetite</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">214</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">657</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">871</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abdominal pain upper</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">236</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">236</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Weight decreased</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">192</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">192</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Headache</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">102</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">—</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">102</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/healthcare-13-02259-t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec3dot2-healthcare-13-02259"><h3 class="pmc_sec_title">3.2. Class-Effective AEs</h3>
<p>Some AEs might be related to the class of the GLP-1/GIP agonists including decreased appetite and weight loss. Also, blood glucose fluctuations were reported in 2023–2024 and may reflect variability in glycemic control in some patients.</p>
<p>As part of our effort to categorize adverse events, we grouped them into the following four main categories: dosing errors, injection-site reactions, gastrointestinal (GI) events, and other adverse drug reactions (ADRs). The most common category was dosing errors, with a total of 30,075 reports during the study period. Dosing errors included incorrect doses, extra doses, accidental underdoses, missed doses, and improper schedules for product administration. There was a significant year-over-year increase in this category, rising from 1715 in 2022 to 15,887 in 2024 and 4241 in Q1 2025 (<a href="#healthcare-13-02259-f001" class="usa-link">Figure 1</a>).</p>
<figure class="fig xbox font-sm" id="healthcare-13-02259-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12469573_healthcare-13-02259-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/062e/12469573/424c942259ad/healthcare-13-02259-g001.jpg" loading="lazy" height="532" width="757" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/healthcare-13-02259-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Trends in adverse event categories (2022—Q1 2025).</p></figcaption></figure><p>Injection-site reactions included 19,334 reports, the second most common category. These reactions included injection-site pain, bleeding, redness, and bruising, with the most reports coming in at 10,245 in 2024.</p>
<p>Gastrointestinal (GI) events, including nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal pain, resulted in a total of 18,018 reports. These events increased consistently over the years, rising from 1423 in 2022 to 8133 in 2024, with 2771 already recorded in Q1 2025.</p>
<p>Other adverse reactions to tirzepatide included off-label use, fatigue, headache, weight loss, and increased blood sugar, totaling 9995 reports. Although this category was the least common overall, it experienced a steady increase from 1153 reports in 2022 to 4532 in 2024.</p></section></section><section id="sec6"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This study reveals several critical insights into the safety profile and real-world use of tirzepatide. The data highlight a significant increase in reported ADEs from 2022 to 2025, with incorrect dose administration emerging as the most prominent issue. This trend aligns with the growing use of tirzepatide, particularly in the United States, which accounted for 96% of the country-specified reports. While there was a study that focused on the AE reports for tirzepatide in the U.S. FAERS database for the period of 2022–2023 [<a href="#B24-healthcare-13-02259" class="usa-link" aria-describedby="B24-healthcare-13-02259">24</a>], our study explored such reported AEs from 2022 through to the first quarter of 2025, providing a more comprehensive view covering the overall safety profile of this medication. The demographics indicate that females were the most frequent reporters, suggesting a potential sex difference (67% female), which aligns with the previous literature showing that females report more ADEs than males [<a href="#B25-healthcare-13-02259" class="usa-link" aria-describedby="B25-healthcare-13-02259">25</a>,<a href="#B26-healthcare-13-02259" class="usa-link" aria-describedby="B26-healthcare-13-02259">26</a>]. Given that tirzepatide is approved by the FDA for the management of type 2 diabetes and obesity, the predominance of reports originating from individuals aged 40–59 years is likely attributable to the high burden of these chronic conditions within this age group [<a href="#B27-healthcare-13-02259" class="usa-link" aria-describedby="B27-healthcare-13-02259">27</a>,<a href="#B28-healthcare-13-02259" class="usa-link" aria-describedby="B28-healthcare-13-02259">28</a>]. However, it is important to note that, as is the nature of the database, there are reports that do not include age information, which limits the detail of age-specific analyses—a common issue in spontaneous reporting systems. One notable trend was the high number of reports submitted by consumers, which accounted for 93.7%. This indicates that there is awareness among consumers/patients about the adverse events that they experienced or the errors that occurred during the usage of the products. Also, since these errors are related to administration, consumers are the most accurate population to describe these events. Moreover, we acknowledge the issue of underreporting by healthcare professionals, especially pharmacists and physicians. Therefore, there is a need to encourage more active reporting from physicians and pharmacists to improve the clinical validity of pharmacovigilance data and support earlier signal detection.</p>
<p>The high number of U.S.-origin reports (96.5%) indicates a regional imbalance that can skew global safety signal detection. This highlights the need for more balanced international participation in pharmacovigilance systems [<a href="#B20-healthcare-13-02259" class="usa-link" aria-describedby="B20-healthcare-13-02259">20</a>,<a href="#B21-healthcare-13-02259" class="usa-link" aria-describedby="B21-healthcare-13-02259">21</a>]. There was a significant increase in report submissions over time, jumping from 5462 in 2022 to 23,497 in 2023, 38,797 in 2024, and 9666 in the first quarter of 2025. The growth in AE reports from 2022 to 2024 could be due to a greater awareness of drug safety, more widespread use of newer medications like tirzepatide, and easier online reporting systems.</p>
<p>In previously published research, there were no reported dose-dependent ADEs [<a href="#B24-healthcare-13-02259" class="usa-link" aria-describedby="B24-healthcare-13-02259">24</a>]. However, the surge in ADEs reported in our study, especially incorrect dose administration, is concerning. The nearly 8-fold increase in such reports from 2022 to 2024 underscores the challenges in prescribing and administering tirzepatide. The consistently elevated risk signals, as evidenced by the high ROR and PRR, further emphasize the strong association between tirzepatide and dosing errors. Although the EBGM and IC showed slight declines in 2024, they remained significant, indicating ongoing safety concerns. The nature and frequency of dosing errors—such as double-dosing, missed doses, or incorrect titration—with tirzepatide mirror those documented for semaglutide and dulaglutide. These errors are primarily attributable to the following two class-wide features: the once-weekly administration schedule, which can cause patients to lose track of their injection day, and the mandatory dose-escalation protocols designed to improve gastrointestinal tolerability [<a href="#B29-healthcare-13-02259" class="usa-link" aria-describedby="B29-healthcare-13-02259">29</a>]. For instance, tirzepatide’s titration from 2.5 mg up to 15 mg is analogous in complexity to semaglutide’s escalation from 0.25 mg to 2.0 mg. There is no evidence to suggest that tirzepatide’s pre-filled pen device, which is similar to that of dulaglutide, or its formulation contributes to a higher rate of user error compared to other agents in the class [<a href="#B30-healthcare-13-02259" class="usa-link" aria-describedby="B30-healthcare-13-02259">30</a>]. Such safety concerns, especially for dose-dependent ADEs of tirzepatide, could lead to severe gastrointestinal AEs, as evident by related clinical trials [<a href="#B31-healthcare-13-02259" class="usa-link" aria-describedby="B31-healthcare-13-02259">31</a>]. These findings suggest a need for enhanced education and training for healthcare providers (e.g., prescribers, pharmacists, and nurses) and patients to mitigate dosing errors and improve medication safety. Such strategies could also mitigate injection-site issues and help such medication users. As the American Diabetes Association has issued practical guidelines for GLP-1 medications’ administration [<a href="#B32-healthcare-13-02259" class="usa-link" aria-describedby="B32-healthcare-13-02259">32</a>], it would be better for clinicians to update their knowledge and educate their patients based on these guidelines to minimize such ADEs.</p>
<p>Injection-site reactions were also among the top reported AEs, with injection-site pain particularly prevalent. These events are consistent with the known side effects of GLP-1/GIP agonists, the class to which tirzepatide belongs [<a href="#B33-healthcare-13-02259" class="usa-link" aria-describedby="B33-healthcare-13-02259">33</a>]. Injection-site reactions, such as erythema, pruritus, and swelling, were reported at a low and consistent frequency across the tirzepatide SURPASS clinical trials, occurring in approximately ≤1–2% of participants [<a href="#B34-healthcare-13-02259" class="usa-link" aria-describedby="B34-healthcare-13-02259">34</a>]. This incidence is directly comparable to the rates observed with other established GLP-1 RAs, including approximately 1% with semaglutide in the SUSTAIN program and 1–2% with dulaglutide in the AWARD trials [<a href="#B30-healthcare-13-02259" class="usa-link" aria-describedby="B30-healthcare-13-02259">30</a>]. These events are typically mild and transient in nature. Their similar prevalence across different molecules indicates they are a consequence of the subcutaneous administration of peptide-based therapies rather than a specific issue related to tirzepatide’s dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonism [<a href="#B29-healthcare-13-02259" class="usa-link" aria-describedby="B29-healthcare-13-02259">29</a>]. These events have persisted over the years, underscoring the importance of proactive management strategies. Providing patient counseling on injection techniques, along with standardized training and clear guidance, can help minimize discomfort, improve tolerability, and boost adherence in long-term injectable therapies.</p>
<p>The third major category was gastrointestinal (GI) adverse events. This is particularly relevant to tirzepatide, as clinical trials (e.g., SURPASS and SURMOUNT studies) and post-marketing surveillance have consistently reported nausea, vomiting, diarrhea, and constipation as the most frequent adverse effects [<a href="#B35-healthcare-13-02259" class="usa-link" aria-describedby="B35-healthcare-13-02259">35</a>]. These symptoms, although often transient, may lead to discontinuation of treatment or dose interruption [<a href="#B36-healthcare-13-02259" class="usa-link" aria-describedby="B36-healthcare-13-02259">36</a>]. A 2024 pharmacovigilance study noted a dose-dependent increase in GI adverse events among tirzepatide users, especially during the initiation and titration phases [<a href="#B37-healthcare-13-02259" class="usa-link" aria-describedby="B37-healthcare-13-02259">37</a>]. These GI adverse events are similar to GLP-1 agonists [<a href="#B33-healthcare-13-02259" class="usa-link" aria-describedby="B33-healthcare-13-02259">33</a>]. Therefore, such surveillance studies are crucial for identifying any major safety concerns with tirzepatide or similar medications as soon as possible. By proactively managing GI side effects through strategies such as dose adjustments, dietary changes, and anti-nausea medication, healthcare providers can help prevent patients treated with tirzepatide from having to discontinue treatment.</p>
<p>The other ADRs category, including fatigue, headache, weight changes, and blood glucose abnormalities, totaled 9995 reports in the EudraVigilance database [<a href="#B38-healthcare-13-02259" class="usa-link" aria-describedby="B38-healthcare-13-02259">38</a>]. The introduction of new AEs, such as blood glucose fluctuations from 2022 to 2024, suggests evolving patterns in tirzepatide use and associated risks [<a href="#B38-healthcare-13-02259" class="usa-link" aria-describedby="B38-healthcare-13-02259">38</a>]. The class-effective adverse events align with the pharmacodynamic effects of tirzepatide. However, the reports of blood glucose variability in some patients indicate the need for careful monitoring, particularly in individuals with diabetes, to ensure optimal glycemic control [<a href="#B35-healthcare-13-02259" class="usa-link" aria-describedby="B35-healthcare-13-02259">35</a>]. These results may reflect broader trends in prescribing practices or challenges in patient adherence and warrant further investigation. Regulatory bodies and institutions should track off-label prescribing patterns, particularly with newer agents like tirzepatide, to ensure appropriate patient selection and risk–benefit analysis.</p>
<section id="sec7"><h3 class="pmc_sec_title">Limitations</h3>
<p>Like most spontaneous reporting systems, this study has several limitations, including underreporting, a lack of denominator data, and missing clinical details, which impact the interpretation of the findings. A large number of reports were missing key demographic and clinical information, as follows: age was unknown in 35.9%, sex was not reported in 12.8%, and clinical outcomes were missing in 89.7% of reports. These gaps may limit the ability to conduct in-depth analyses, estimate incidence rates, or draw firm conclusions about causality and severity. Furthermore, the data show a strong geographic concentration, with 96.5% of reports coming from the United States. This regional bias may limit the applicability of the findings and could mask potential safety signals in other populations or healthcare systems. Additionally, causality cannot be deduced from the FAERS data, and duplicated or incomplete reports might affect signal strength. Due to the spontaneous nature of the FAERS reports, the causality between tirzepatide and the reported adverse events cannot be established. The data reflect associations that may suggest a potential safety signal but do not confirm direct cause–effect relationships. Therefore, future research might be needed to explore the underlying causes of these AEs and evaluate the effectiveness of mitigation strategies in real-world settings. Furthermore, qualitative research investigating the underlying reasons and factors that may lead to such safety concerns from users’ and healthcare providers’ perspectives may be essential to reduce these concerns for these medications or similar ones.</p></section></section><section id="sec5-healthcare-13-02259"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>Tirzepatide’s increasing use in the management of diabetes and obesity is reflected in emerging pharmacovigilance trends. The findings underscore the importance of vigilant monitoring and targeted interventions to address the safety concerns associated with tirzepatide, particularly dosing errors and injection-site reactions. Healthcare providers should prioritize patient education, clear dosing instructions, and regular follow-ups to minimize risks.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>H.A.A. and T.M.A.: Conceptualization, methodology, formal analysis, writing—original draft, and writing—review and editing. H.A.T., A.A.K., M.A. and S.A.A.-Q.: writing—original draft and writing—review and editing. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>This study did not involve human subjects or animal experimentation. The data used in this research were obtained from the FDA Adverse Event Reporting System (FAERS), which is a publicly accessible database containing de-identified post-marketing safety reports submitted by consumers, healthcare professionals, and pharmaceutical companies. As such, this retrospective analysis involves secondary data analysis of anonymous, publicly available data and does not meet the regulatory definition of human subject research under the U.S. Code of Federal Regulations (45 CFR 46). Therefore, approval from an Institutional Review Board (IRB) is not applicable, and a waiver is hereby requested.</p></section><section id="notes3"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Similarly, this study did not involve the collection, use, or analysis of identifiable private information. The FAERS database contains no personally identifiable information (PII), and all analyses were conducted in aggregate. In accordance with ethical guidelines and data protection laws, including the Declaration of Helsinki and global best practices for retrospective secondary data analysis, the requirement for informed consent is deemed not applicable.</p></section><section id="notes4"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The FDA Adverse Event Reporting System (FAERS) quarterly data extract files are publicly available and can be obtained at the following: <a href="https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html</a> (accessed on 5 April 2025).</p></section><section id="notes5"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare they have no competing interests.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This research received no external funding.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Disclaimer/Publisher’s Note:</strong> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-healthcare-13-02259">
<span class="label">1.</span><cite>Garvey W.T., Frias J.P., Jastreboff A.M., le Roux C.W., Sattar N., Aizenberg D., Mao H., Zhang S., Ahmad N.N., Bunck M.C., et al.  Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023;402:613–626. doi: 10.1016/S0140-6736(23)01200-X.</cite> [<a href="https://doi.org/10.1016/S0140-6736(23)01200-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37385275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Tirzepatide%20once%20weekly%20for%20the%20treatment%20of%20obesity%20in%20people%20with%20type%202%20diabetes%20(SURMOUNT-2):%20A%20double-blind,%20randomised,%20multicentre,%20placebo-controlled,%20phase%203%20trial&amp;author=W.T.%20Garvey&amp;author=J.P.%20Frias&amp;author=A.M.%20Jastreboff&amp;author=C.W.%20le%20Roux&amp;author=N.%20Sattar&amp;volume=402&amp;publication_year=2023&amp;pages=613-626&amp;pmid=37385275&amp;doi=10.1016/S0140-6736(23)01200-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-healthcare-13-02259">
<span class="label">2.</span><cite>Chavda V.P., Ajabiya J., Teli D., Bojarska J., Apostolopoulos V. Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: A mini-review. Molecules. 2022;27:4315.  doi: 10.3390/molecules27134315.</cite> [<a href="https://doi.org/10.3390/molecules27134315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9268041/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35807558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Tirzepatide,%20a%20new%20era%20of%20dual-targeted%20treatment%20for%20diabetes%20and%20obesity:%20A%20mini-review&amp;author=V.P.%20Chavda&amp;author=J.%20Ajabiya&amp;author=D.%20Teli&amp;author=J.%20Bojarska&amp;author=V.%20Apostolopoulos&amp;volume=27&amp;publication_year=2022&amp;pages=4315&amp;pmid=35807558&amp;doi=10.3390/molecules27134315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-healthcare-13-02259">
<span class="label">3.</span><cite>Moiz A., Khan T., Masood Q., Malik B.H. Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: A systematic review of randomized controlled trials. Ann. Intern. Med. 2025;178:199–217. doi: 10.7326/ANNALS-24-01590.</cite> [<a href="https://doi.org/10.7326/ANNALS-24-01590" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39761578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Intern.%20Med.&amp;title=Efficacy%20and%20safety%20of%20glucagon-like%20peptide-1%20receptor%20agonists%20for%20weight%20loss%20among%20adults%20without%20diabetes:%20A%20systematic%20review%20of%20randomized%20controlled%20trials&amp;author=A.%20Moiz&amp;author=T.%20Khan&amp;author=Q.%20Masood&amp;author=B.H.%20Malik&amp;volume=178&amp;publication_year=2025&amp;pages=199-217&amp;pmid=39761578&amp;doi=10.7326/ANNALS-24-01590&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-healthcare-13-02259">
<span class="label">4.</span><cite>Zupec J., Munger R., Scaletta A., Quinn D.H. Use of glucagon-like peptide-1 receptor agonists and incretin mimetics for type 2 diabetes and obesity: A narrative review. Nutr. Clin. Pract. 2025;40:327–349. doi: 10.1002/ncp.11279.</cite> [<a href="https://doi.org/10.1002/ncp.11279" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39961620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nutr.%20Clin.%20Pract.&amp;title=Use%20of%20glucagon-like%20peptide-1%20receptor%20agonists%20and%20incretin%20mimetics%20for%20type%202%20diabetes%20and%20obesity:%20A%20narrative%20review&amp;author=J.%20Zupec&amp;author=R.%20Munger&amp;author=A.%20Scaletta&amp;author=D.H.%20Quinn&amp;volume=40&amp;publication_year=2025&amp;pages=327-349&amp;pmid=39961620&amp;doi=10.1002/ncp.11279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-healthcare-13-02259">
<span class="label">5.</span><cite>Febrey S., Jones L., Jones D., Hicks K. What are the experiences, views and perceptions of patients, carers and clinicians of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)? A scoping review. Health Expect. 2025;28:e70251. doi: 10.1111/hex.70251.</cite> [<a href="https://doi.org/10.1111/hex.70251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11995417/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40227008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Health%20Expect.&amp;title=What%20are%20the%20experiences,%20views%20and%20perceptions%20of%20patients,%20carers%20and%20clinicians%20of%20glucagon-like%20peptide-1%20receptor%20agonists%20(GLP-1%20RAs)?%20A%20scoping%20review&amp;author=S.%20Febrey&amp;author=L.%20Jones&amp;author=D.%20Jones&amp;author=K.%20Hicks&amp;volume=28&amp;publication_year=2025&amp;pages=e70251&amp;pmid=40227008&amp;doi=10.1111/hex.70251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-healthcare-13-02259">
<span class="label">6.</span><cite>Ruder K. Patients are flocking to compounded weight-loss drugs, but are they safe? JAMA. 2025;333:652–655. doi: 10.1001/jama.2024.27251.</cite> [<a href="https://doi.org/10.1001/jama.2024.27251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39854000/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Patients%20are%20flocking%20to%20compounded%20weight-loss%20drugs,%20but%20are%20they%20safe?&amp;author=K.%20Ruder&amp;volume=333&amp;publication_year=2025&amp;pages=652-655&amp;pmid=39854000&amp;doi=10.1001/jama.2024.27251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-healthcare-13-02259">
<span class="label">7.</span><cite>Takyi A.K., Gaffey R.H., Shukla A.P. Optimizing the efficacy of anti-obesity medications: A practical guide to personalizing incretin-based therapies. Curr. Treat. Options Gastroenterol. 2025;23:2. doi: 10.1007/s11938-024-00465-1.</cite> [<a href="https://doi.org/10.1007/s11938-024-00465-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr.%20Treat.%20Options%20Gastroenterol.&amp;title=Optimizing%20the%20efficacy%20of%20anti-obesity%20medications:%20A%20practical%20guide%20to%20personalizing%20incretin-based%20therapies&amp;author=A.K.%20Takyi&amp;author=R.H.%20Gaffey&amp;author=A.P.%20Shukla&amp;volume=23&amp;publication_year=2025&amp;pages=2&amp;doi=10.1007/s11938-024-00465-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-healthcare-13-02259">
<span class="label">8.</span><cite>Ntani S.N., Sangha Y.M.N. Prevalence and causes of medication transcription errors among hospitalized patients: An observational study and survey of nurses at a faith-based hospital in Cameroon. Glob. Health Econ. Sustain. 2024;2:2457. doi: 10.36922/ghes.2457.</cite> [<a href="https://doi.org/10.36922/ghes.2457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Glob.%20Health%20Econ.%20Sustain.&amp;title=Prevalence%20and%20causes%20of%20medication%20transcription%20errors%20among%20hospitalized%20patients:%20An%20observational%20study%20and%20survey%20of%20nurses%20at%20a%20faith-based%20hospital%20in%20Cameroon&amp;author=S.N.%20Ntani&amp;author=Y.M.N.%20Sangha&amp;volume=2&amp;publication_year=2024&amp;pages=2457&amp;doi=10.36922/ghes.2457&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-healthcare-13-02259">
<span class="label">9.</span><cite>Vest T.A., Gazda N.P., O’Neil D.P., Eckel S.F. Practice-enhancing publications about the medication-use process in 2021. Am. J. Health Syst. Pharm. 2024;81:e489–e519. doi: 10.1093/ajhp/zxae144.</cite> [<a href="https://doi.org/10.1093/ajhp/zxae144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38864424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Health%20Syst.%20Pharm.&amp;title=Practice-enhancing%20publications%20about%20the%20medication-use%20process%20in%202021&amp;author=T.A.%20Vest&amp;author=N.P.%20Gazda&amp;author=D.P.%20O%E2%80%99Neil&amp;author=S.F.%20Eckel&amp;volume=81&amp;publication_year=2024&amp;pages=e489-e519&amp;pmid=38864424&amp;doi=10.1093/ajhp/zxae144&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-healthcare-13-02259">
<span class="label">10.</span><cite>Assiri G.A., Shebl N.A., Mahmoud M.A., Aloudah N., Grant E., Aljadhey H., Sheikh A. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. BMJ Open. 2018;8:e019101. doi: 10.1136/bmjopen-2017-019101.</cite> [<a href="https://doi.org/10.1136/bmjopen-2017-019101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5942474/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29730617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=What%20is%20the%20epidemiology%20of%20medication%20errors,%20error-related%20adverse%20events%20and%20risk%20factors%20for%20errors%20in%20adults%20managed%20in%20community%20care%20contexts?%20A%20systematic%20review%20of%20the%20international%20literature&amp;author=G.A.%20Assiri&amp;author=N.A.%20Shebl&amp;author=M.A.%20Mahmoud&amp;author=N.%20Aloudah&amp;author=E.%20Grant&amp;volume=8&amp;publication_year=2018&amp;pages=e019101&amp;pmid=29730617&amp;doi=10.1136/bmjopen-2017-019101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-healthcare-13-02259">
<span class="label">11.</span><cite>George J., Dsouza P.L., Jahnavi Y., Singh H., Kumar P.A.  Signal Analysis in Pharmacovigilance. CRC Press; Boca Raton, FL, USA: 2024. Databases and tools for signal detection of drugs in post-marketing surveillance; pp. 32–43.</cite> [<a href="https://doi.org/10.1201/9781032629940-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Signal%20Analysis%20in%20Pharmacovigilance&amp;author=J.%20George&amp;author=P.L.%20Dsouza&amp;author=Y.%20Jahnavi&amp;author=H.%20Singh&amp;author=P.A.%20Kumar&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-healthcare-13-02259">
<span class="label">12.</span><cite>Christaki E., Protopapa C., Siamidi A., Vlachou M. Obesity management: An update on the available pharmacotherapy. Innov. Med. Omics. 2025;2:8316. doi: 10.36922/imo.8316.</cite> [<a href="https://doi.org/10.36922/imo.8316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Innov.%20Med.%20Omics&amp;title=Obesity%20management:%20An%20update%20on%20the%20available%20pharmacotherapy&amp;author=E.%20Christaki&amp;author=C.%20Protopapa&amp;author=A.%20Siamidi&amp;author=M.%20Vlachou&amp;volume=2&amp;publication_year=2025&amp;pages=8316&amp;doi=10.36922/imo.8316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-healthcare-13-02259">
<span class="label">13.</span><cite>Lupianez-Merly C., Dilmaghani S., Vosoughi K., Camilleri M. Review article: Pharmacologic management of obesity—Updates on approved medications, indications and risks. Aliment. Pharmacol. Ther. 2024;59:475–491. doi: 10.1111/apt.17856.</cite> [<a href="https://doi.org/10.1111/apt.17856" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38169126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aliment.%20Pharmacol.%20Ther.&amp;title=Review%20article:%20Pharmacologic%20management%20of%20obesity%E2%80%94Updates%20on%20approved%20medications,%20indications%20and%20risks&amp;author=C.%20Lupianez-Merly&amp;author=S.%20Dilmaghani&amp;author=K.%20Vosoughi&amp;author=M.%20Camilleri&amp;volume=59&amp;publication_year=2024&amp;pages=475-491&amp;pmid=38169126&amp;doi=10.1111/apt.17856&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-healthcare-13-02259">
<span class="label">14.</span><cite>Abi Zeid Daou C., Aboul Hosn O., Ghzayel L., Mourad M. Exploring connections between weight-loss medications and thyroid cancer: A look at the FDA Adverse Event Reporting System database. Endocrinol. Diabetes Metab. 2025;8:e70038. doi: 10.1002/edm2.70038.</cite> [<a href="https://doi.org/10.1002/edm2.70038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11889434/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40055991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinol.%20Diabetes%20Metab.&amp;title=Exploring%20connections%20between%20weight-loss%20medications%20and%20thyroid%20cancer:%20A%20look%20at%20the%20FDA%20Adverse%20Event%20Reporting%20System%20database&amp;author=C.%20Abi%20Zeid%20Daou&amp;author=O.%20Aboul%20Hosn&amp;author=L.%20Ghzayel&amp;author=M.%20Mourad&amp;volume=8&amp;publication_year=2025&amp;pages=e70038&amp;pmid=40055991&amp;doi=10.1002/edm2.70038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-healthcare-13-02259">
<span class="label">15.</span><cite>McIntyre R.S., Kwan A.T.H. Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: A population-based study.  [(accessed on 5 September 2025)];Expert Opinion on Drug Safety. 2024  doi: 10.1080/14740338.2024.2430306. Available online:  <a href="https://pubmed.ncbi.nlm.nih.gov/39552465/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39552465/</a></cite> [<a href="https://doi.org/10.1080/14740338.2024.2430306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39552465/" class="usa-link">PubMed</a>]</li>
<li id="B16-healthcare-13-02259">
<span class="label">16.</span><cite>Chiappini S., Guirguis A., John A., Corkery J.M., Schifano F. Is there a risk for semaglutide misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) pharmacovigilance dataset. Pharmaceuticals. 2023;16:994.  doi: 10.3390/ph16070994.</cite> [<a href="https://doi.org/10.3390/ph16070994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10384093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37513906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Is%20there%20a%20risk%20for%20semaglutide%20misuse?%20Focus%20on%20the%20Food%20and%20Drug%20Administration%E2%80%99s%20FDA%20Adverse%20Events%20Reporting%20System%20(FAERS)%20pharmacovigilance%20dataset&amp;author=S.%20Chiappini&amp;author=A.%20Guirguis&amp;author=A.%20John&amp;author=J.M.%20Corkery&amp;author=F.%20Schifano&amp;volume=16&amp;publication_year=2023&amp;pages=994&amp;pmid=37513906&amp;doi=10.3390/ph16070994&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-healthcare-13-02259">
<span class="label">17.</span><cite>Barnes J.  Pharmacovigilance for Herbal and Traditional Medicines: Advances, Challenges and International Perspectives. 2022.  [(accessed on 5 September 2025)]. Advances in methods and techniques in pharmacovigilance for herbal and traditional medicines and other natural health products; pp. 93–139. Available online:  <a href="https://www.scribd.com/document/766337469/Joanne-Barnes-Pharmacovigilance-for-Herbal-and-Traditional-Medicines-Advances-Challenges-and-International-Perspectives-Adis-2022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.scribd.com/document/766337469/Joanne-Barnes-Pharmacovigilance-for-Herbal-and-Traditional-Medicines-Advances-Challenges-and-International-Perspectives-Adis-2022</a>.</cite> [<a href="https://doi.org/10.1007/978-3-031-07275-8_7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Pharmacovigilance%20for%20Herbal%20and%20Traditional%20Medicines:%20Advances,%20Challenges%20and%20International%20Perspectives&amp;author=J.%20Barnes&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-healthcare-13-02259">
<span class="label">18.</span><cite>Chen W., Cai P., Zou W., Fu Z. Psychiatric adverse events associated with GLP-1 receptor agonists: A real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database. Front. Endocrinol. 2024;15:1330936.  doi: 10.3389/fendo.2024.1330936.</cite> [<a href="https://doi.org/10.3389/fendo.2024.1330936" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10882716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38390214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Endocrinol.&amp;title=Psychiatric%20adverse%20events%20associated%20with%20GLP-1%20receptor%20agonists:%20A%20real-world%20pharmacovigilance%20study%20based%20on%20the%20FDA%20Adverse%20Event%20Reporting%20System%20database&amp;author=W.%20Chen&amp;author=P.%20Cai&amp;author=W.%20Zou&amp;author=Z.%20Fu&amp;volume=15&amp;publication_year=2024&amp;pages=1330936&amp;pmid=38390214&amp;doi=10.3389/fendo.2024.1330936&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-healthcare-13-02259">
<span class="label">19.</span><cite>U.S. Food and Drug Administration;  [(accessed on 4 June 2025)]. FAERS Quarterly Data Extract Files [Internet] Available online:  <a href="https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?U.S.%20Food%20and%20Drug%20Administration;%20%5B(accessed%20on%204%20June%202025)%5D.%20FAERS%20Quarterly%20Data%20Extract%20Files%20%5BInternet%5D%20Available%20online:%20https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-healthcare-13-02259">
<span class="label">20.</span><cite>Alenzi K.A., Alsuhaibani D., Batarfi B., Alshammari T.M. Pancreatitis with use of new diabetic medications: A real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database. Front. Pharmacol. 2024;15:1364110.  doi: 10.3389/fphar.2024.1364110.</cite> [<a href="https://doi.org/10.3389/fphar.2024.1364110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11163090/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38860168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol.&amp;title=Pancreatitis%20with%20use%20of%20new%20diabetic%20medications:%20A%20real-world%20data%20study%20using%20the%20post-marketing%20FDA%20adverse%20event%20reporting%20system%20(FAERS)%20database&amp;author=K.A.%20Alenzi&amp;author=D.%20Alsuhaibani&amp;author=B.%20Batarfi&amp;author=T.M.%20Alshammari&amp;volume=15&amp;publication_year=2024&amp;pages=1364110&amp;pmid=38860168&amp;doi=10.3389/fphar.2024.1364110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-healthcare-13-02259">
<span class="label">21.</span><cite>Alshammari T.M., Ata S.I., Mahmoud M.A., Alhawassi T.M., Aljadhey H.S. Signals of bleeding among direct-acting oral anticoagulant users compared to those among warfarin users: Analyses of the post-marketing FDA Adverse Event Reporting System (FAERS) database, 2010–2015. Ther. Clin. Risk Manag. 2018;14:803–809. doi: 10.2147/TCRM.S161148.</cite> [<a href="https://doi.org/10.2147/TCRM.S161148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5936487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29750038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ther.%20Clin.%20Risk%20Manag.&amp;title=Signals%20of%20bleeding%20among%20direct-acting%20oral%20anticoagulant%20users%20compared%20to%20those%20among%20warfarin%20users:%20Analyses%20of%20the%20post-marketing%20FDA%20Adverse%20Event%20Reporting%20System%20(FAERS)%20database,%202010%E2%80%932015&amp;author=T.M.%20Alshammari&amp;author=S.I.%20Ata&amp;author=M.A.%20Mahmoud&amp;author=T.M.%20Alhawassi&amp;author=H.S.%20Aljadhey&amp;volume=14&amp;publication_year=2018&amp;pages=803-809&amp;pmid=29750038&amp;doi=10.2147/TCRM.S161148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-healthcare-13-02259">
<span class="label">22.</span><cite>Altebainawi A.F., Alfaraj L.A., Alharbi A.A., Alkhuraisi F.F., Alshammari T.M. Association between proton pump inhibitors and rhabdomyolysis risk: A post-marketing surveillance using FDA adverse event reporting system (FAERS) database. Ther. Adv. Drug Saf. 2023;14 doi: 10.1177/20420986231154075.</cite> [<a href="https://doi.org/10.1177/20420986231154075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9974623/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36875514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ther.%20Adv.%20Drug%20Saf.&amp;title=Association%20between%20proton%20pump%20inhibitors%20and%20rhabdomyolysis%20risk:%20A%20post-marketing%20surveillance%20using%20FDA%20adverse%20event%20reporting%20system%20(FAERS)%20database&amp;author=A.F.%20Altebainawi&amp;author=L.A.%20Alfaraj&amp;author=A.A.%20Alharbi&amp;author=F.F.%20Alkhuraisi&amp;author=T.M.%20Alshammari&amp;volume=14&amp;publication_year=2023&amp;pmid=36875514&amp;doi=10.1177/20420986231154075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-healthcare-13-02259">
<span class="label">23.</span><cite>Thaibah H.A., Banji O.J.F., Banji D., Alshammari T.M. Diabetic ketoacidosis and the use of new hypoglycemic groups: Real-world evidence utilizing the Food and Drug Administration Adverse Event Reporting System. Pharmaceuticals. 2025;18:214.  doi: 10.3390/ph18020214.</cite> [<a href="https://doi.org/10.3390/ph18020214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11858861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40006028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Diabetic%20ketoacidosis%20and%20the%20use%20of%20new%20hypoglycemic%20groups:%20Real-world%20evidence%20utilizing%20the%20Food%20and%20Drug%20Administration%20Adverse%20Event%20Reporting%20System&amp;author=H.A.%20Thaibah&amp;author=O.J.F.%20Banji&amp;author=D.%20Banji&amp;author=T.M.%20Alshammari&amp;volume=18&amp;publication_year=2025&amp;pages=214&amp;pmid=40006028&amp;doi=10.3390/ph18020214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-healthcare-13-02259">
<span class="label">24.</span><cite>Chen H., Ding Y., Shan Y. Post-marketing safety monitoring of tirzepatide: A pharmacovigilance study based on the FAERS database. Expert Opin. Drug Saf. 2025;8:959–967. doi: 10.1080/14740338.2025.2468860.</cite> [<a href="https://doi.org/10.1080/14740338.2025.2468860" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40037695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin.%20Drug%20Saf.&amp;title=Post-marketing%20safety%20monitoring%20of%20tirzepatide:%20A%20pharmacovigilance%20study%20based%20on%20the%20FAERS%20database&amp;author=H.%20Chen&amp;author=Y.%20Ding&amp;author=Y.%20Shan&amp;volume=8&amp;publication_year=2025&amp;pages=959-967&amp;pmid=40037695&amp;doi=10.1080/14740338.2025.2468860&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-healthcare-13-02259">
<span class="label">25.</span><cite>Zopf Y., Rabe C., Neubert A., Gassmann K.G., Rascher W., Hahn E.G., Brune K., Dormann H. Women encounter ADRs more often than do men. Eur. J. Clin. Pharmacol. 2008;64:999–1004. doi: 10.1007/s00228-008-0494-6.</cite> [<a href="https://doi.org/10.1007/s00228-008-0494-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18604529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Clin.%20Pharmacol.&amp;title=Women%20encounter%20ADRs%20more%20often%20than%20do%20men&amp;author=Y.%20Zopf&amp;author=C.%20Rabe&amp;author=A.%20Neubert&amp;author=K.G.%20Gassmann&amp;author=W.%20Rascher&amp;volume=64&amp;publication_year=2008&amp;pages=999-1004&amp;pmid=18604529&amp;doi=10.1007/s00228-008-0494-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-healthcare-13-02259">
<span class="label">26.</span><cite>Watson S., Caster O., Rochon P.A., den Ruijter H. Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine. 2019;17:100188. doi: 10.1016/j.eclinm.2019.10.001.</cite> [<a href="https://doi.org/10.1016/j.eclinm.2019.10.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6933269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31891132/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&amp;title=Reported%20adverse%20drug%20reactions%20in%20women%20and%20men:%20Aggregated%20evidence%20from%20globally%20collected%20individual%20case%20reports%20during%20half%20a%20century&amp;author=S.%20Watson&amp;author=O.%20Caster&amp;author=P.A.%20Rochon&amp;author=H.%20den%20Ruijter&amp;volume=17&amp;publication_year=2019&amp;pages=100188&amp;pmid=31891132&amp;doi=10.1016/j.eclinm.2019.10.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-healthcare-13-02259">
<span class="label">27.</span><cite>Centers for Disease Control and Prevention;  [(accessed on 1 June 2025)]. Adult Obesity Prevalence Maps [Internet] Available online:  <a href="https://www.cdc.gov/obesity/data-and-statistics/adult-obesity-prevalence-maps.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/obesity/data-and-statistics/adult-obesity-prevalence-maps.html</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?Centers%20for%20Disease%20Control%20and%20Prevention;%20%5B(accessed%20on%201%20June%202025)%5D.%20Adult%20Obesity%20Prevalence%20Maps%20%5BInternet%5D%20Available%20online:%20https://www.cdc.gov/obesity/data-and-statistics/adult-obesity-prevalence-maps.html." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-healthcare-13-02259">
<span class="label">28.</span><cite>Goyal R., Singhal M., Jialal I.  StatPearls; 2023.  [(accessed on 1 June 2025)]. Type 2 Diabetes [Internet] Available online:  <a href="https://www.ncbi.nlm.nih.gov/books/NBK513253/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK513253/</a></cite> [<a href="https://scholar.google.com/scholar_lookup?Goyal%20R.,%20Singhal%20M.,%20Jialal%20I.%20StatPearls;%202023.%20%5B(accessed%20on%201%20June%202025)%5D.%20Type%202%20Diabetes%20%5BInternet%5D%20Available%20online:%20https://www.ncbi.nlm.nih.gov/books/NBK513253/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-healthcare-13-02259">
<span class="label">29.</span><cite>Farzam K., Patel P.  StatPearls [Internet] StatPearls Publishing; St. Petersburg, FL, USA: 2024. Tirzepatide.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=StatPearls%20%5BInternet%5D&amp;author=K.%20Farzam&amp;author=P.%20Patel&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-healthcare-13-02259">
<span class="label">30.</span><cite>Karagiannis T., Malandris K., Avgerinos I., Stamati A., Kakotrichi P., Liakos A., Vasilakou D., Kakaletsis N., Tsapas A., Bekiari E. Subcutaneously administered tirzepatide vs. semaglutide for adults with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials. Diabetologia. 2024;67:1206–1222. doi: 10.1007/s00125-024-06144-1.</cite> [<a href="https://doi.org/10.1007/s00125-024-06144-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11153294/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38613667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Subcutaneously%20administered%20tirzepatide%20vs.%20semaglutide%20for%20adults%20with%20type%202%20diabetes:%20A%20systematic%20review%20and%20network%20meta-analysis%20of%20randomised%20controlled%20trials&amp;author=T.%20Karagiannis&amp;author=K.%20Malandris&amp;author=I.%20Avgerinos&amp;author=A.%20Stamati&amp;author=P.%20Kakotrichi&amp;volume=67&amp;publication_year=2024&amp;pages=1206-1222&amp;pmid=38613667&amp;doi=10.1007/s00125-024-06144-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-healthcare-13-02259">
<span class="label">31.</span><cite>Yao H., Liu J., Zhang R., Li R., Wang Y., Sun X., Yuan C.S. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: Systematic review and network meta-analysis. BMJ. 2024;384:e076410. doi: 10.1136/bmj-2023-076410.</cite> [<a href="https://doi.org/10.1136/bmj-2023-076410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10823535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38286487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Comparative%20effectiveness%20of%20GLP-1%20receptor%20agonists%20on%20glycaemic%20control,%20body%20weight,%20and%20lipid%20profile%20for%20type%202%20diabetes:%20Systematic%20review%20and%20network%20meta-analysis&amp;author=H.%20Yao&amp;author=J.%20Liu&amp;author=R.%20Zhang&amp;author=R.%20Li&amp;author=Y.%20Wang&amp;volume=384&amp;publication_year=2024&amp;pages=e076410&amp;pmid=38286487&amp;doi=10.1136/bmj-2023-076410&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-healthcare-13-02259">
<span class="label">32.</span><cite>American Diabetes Association Professional Practice Committee  7. Diabetes Technology: Standards of Care in Diabetes—2024. Diabetes Care. 2024;47((Suppl. 1)):S126–S144. doi: 10.2337/dc24-S007.</cite> [<a href="https://doi.org/10.2337/dc24-S007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10725813/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38078575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=7.%20Diabetes%20Technology:%20Standards%20of%20Care%20in%20Diabetes%E2%80%942024&amp;volume=47&amp;issue=(Suppl.%201)&amp;publication_year=2024&amp;pages=S126-S144&amp;pmid=38078575&amp;doi=10.2337/dc24-S007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-healthcare-13-02259">
<span class="label">33.</span><cite>Filippatos T.D., Panagiotopoulou T.V., Elisaf M.S. Adverse effects of GLP-1 receptor agonists. Rev. Diabet. Stud. 2015;11:202. doi: 10.1900/RDS.2014.11.202.</cite> [<a href="https://doi.org/10.1900/RDS.2014.11.202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5397288/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26177483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev.%20Diabet.%20Stud.&amp;title=Adverse%20effects%20of%20GLP-1%20receptor%20agonists&amp;author=T.D.%20Filippatos&amp;author=T.V.%20Panagiotopoulou&amp;author=M.S.%20Elisaf&amp;volume=11&amp;publication_year=2015&amp;pages=202&amp;pmid=26177483&amp;doi=10.1900/RDS.2014.11.202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-healthcare-13-02259">
<span class="label">34.</span><cite>Karagiannis T., Avgerinos I., Liakos A., Del Prato S., Matthews D.R., Tsapas A., Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: A systematic review and meta-analysis. Diabetologia. 2022;65:1251–1261. doi: 10.1007/s00125-022-05715-4.</cite> [<a href="https://doi.org/10.1007/s00125-022-05715-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9112245/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35579691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Management%20of%20type%202%20diabetes%20with%20the%20dual%20GIP/GLP-1%20receptor%20agonist%20tirzepatide:%20A%20systematic%20review%20and%20meta-analysis&amp;author=T.%20Karagiannis&amp;author=I.%20Avgerinos&amp;author=A.%20Liakos&amp;author=S.%20Del%20Prato&amp;author=D.R.%20Matthews&amp;volume=65&amp;publication_year=2022&amp;pages=1251-1261&amp;pmid=35579691&amp;doi=10.1007/s00125-022-05715-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-healthcare-13-02259">
<span class="label">35.</span><cite>Liu L. A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database. Front. Pharmacol. 2024;15:1397029.  doi: 10.3389/fphar.2024.1502047.</cite> [<a href="https://doi.org/10.3389/fphar.2024.1502047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11190169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38910884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Pharmacol.&amp;title=A%20real-world%20data%20analysis%20of%20tirzepatide%20in%20the%20FDA%20adverse%20event%20reporting%20system%20(FAERS)%20database&amp;author=L.%20Liu&amp;volume=15&amp;publication_year=2024&amp;pages=1397029&amp;pmid=38910884&amp;doi=10.3389/fphar.2024.1502047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-healthcare-13-02259">
<span class="label">36.</span><cite>Jastreboff A.M., Aronne L.J., Ahmad N.N., Wharton S., Connery L., Alves B., Kiyosue A., Zhang S., Liu B., Bunck M.C., et al.  Tirzepatide once weekly for the treatment of obesity. N. Engl. J. Med. 2022;387:205–216. doi: 10.1056/NEJMoa2206038.</cite> [<a href="https://doi.org/10.1056/NEJMoa2206038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35658024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Tirzepatide%20once%20weekly%20for%20the%20treatment%20of%20obesity&amp;author=A.M.%20Jastreboff&amp;author=L.J.%20Aronne&amp;author=N.N.%20Ahmad&amp;author=S.%20Wharton&amp;author=L.%20Connery&amp;volume=387&amp;publication_year=2022&amp;pages=205-216&amp;pmid=35658024&amp;doi=10.1056/NEJMoa2206038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-healthcare-13-02259">
<span class="label">37.</span><cite>Caruso I., Cari L., Berardicurti O., Di Nisio C., Di Michele L., Di Giovanni P., Laviola L., Giorgino F. The real-world safety profile of tirzepatide: Pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database. J. Endocrinol. Investig. 2024;47:2671–2678. doi: 10.1007/s40618-024-02441-z.</cite> [<a href="https://doi.org/10.1007/s40618-024-02441-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11473560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39141075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Endocrinol.%20Investig.&amp;title=The%20real-world%20safety%20profile%20of%20tirzepatide:%20Pharmacovigilance%20analysis%20of%20the%20FDA%20Adverse%20Event%20Reporting%20System%20(FAERS)%20database&amp;author=I.%20Caruso&amp;author=L.%20Cari&amp;author=O.%20Berardicurti&amp;author=C.%20Di%20Nisio&amp;author=L.%20Di%20Michele&amp;volume=47&amp;publication_year=2024&amp;pages=2671-2678&amp;pmid=39141075&amp;doi=10.1007/s40618-024-02441-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-healthcare-13-02259">
<span class="label">38.</span><cite>Khurana A., Kaur R., Sharma S., Singh G., Kapoor D. Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database. Clin. Epidemiol. Glob. Health. 2024;30:101805. doi: 10.1016/j.cegh.2024.101805.</cite> [<a href="https://doi.org/10.1016/j.cegh.2024.101805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Epidemiol.%20Glob.%20Health&amp;title=Safety%20profile%20of%20tirzepatide:%20A%20real-world%20pharmacovigilance%20analysis%20of%20EudraVigilance%20database&amp;author=A.%20Khurana&amp;author=R.%20Kaur&amp;author=S.%20Sharma&amp;author=G.%20Singh&amp;author=D.%20Kapoor&amp;volume=30&amp;publication_year=2024&amp;pages=101805&amp;doi=10.1016/j.cegh.2024.101805&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The FDA Adverse Event Reporting System (FAERS) quarterly data extract files are publicly available and can be obtained at the following: <a href="https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html</a> (accessed on 5 April 2025).</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Healthcare are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/healthcare13182259"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/healthcare-13-02259.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (247.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12469573/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12469573/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12469573%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12469573/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12469573/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12469573/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/41008391/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12469573/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/41008391/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12469573/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12469573/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="QTuFdyNEoPxjsqrFQrEQ17hhuGlfiIvcJ4vS9E0gHY9hBOvraHOWkO5r89u9a8Ph">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-B7-tgZZA.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-BLbQGH8u.js"></script>
    
    

    </body>
</html>
